CET+and+Interp+ C5 6
Transcript of CET+and+Interp+ C5 6
-
8/13/2019 CET+and+Interp+ C5 6
1/30
Clinical Exercise Testing-
ApplicationsPre-discharge/post MI, PTCA, CABGFunctionalDisease progressionDisability/Return to WorkDiagnostic (usually Bruce TM test)
chest paindyspneasyncope/dizziness
-
8/13/2019 CET+and+Interp+ C5 6
2/30
Diagnostic Testing-Measurements
HR (85% PMHR) & BpSigns and symptoms
EKG (ectopic beats and ST segment changes)
1mm @ .08 sec = significant ST segment
depression = ischemia
-
8/13/2019 CET+and+Interp+ C5 6
3/30
-
8/13/2019 CET+and+Interp+ C5 6
4/30
ST-T wave segment changes
ST depression
ST elevation
T wave inversion
Ischemia
-
8/13/2019 CET+and+Interp+ C5 6
5/30
ST segment slope
Upslope less suggestive
Flat more suggestive
Downslope most suggestive
Magnitude of ischemia
-
8/13/2019 CET+and+Interp+ C5 6
6/30
ST Segment Depression
-
8/13/2019 CET+and+Interp+ C5 6
7/30
Magnitude of ischemia is
directly proportional to:ST segment slope
# of EKG leads involvedPersistence of ST-T wave changes duringrecoveryAmount of ST depression (1mm vs. 5)
-
8/13/2019 CET+and+Interp+ C5 6
8/30
Sensitivity/Specificity
Sensitivity -% of patients tested who haveCAD and an abnormal test (ST chgs.)
TPR=70% ; FPR30%
Specificity -% of patients w/o CAD who will
have a negative testTNR=80% ; FNR=20%
-
8/13/2019 CET+and+Interp+ C5 6
9/30
False Positive Rate=30% / Factorscontributing to FPR
Female gender (Thallium GXT)
Resting ECG changes (LVH)
Some meds (digitalis)
-
8/13/2019 CET+and+Interp+ C5 6
10/30
Magnitude of ischemia isinversely proportional to:
Double product (rate pressure product) SBP xHRMaximal HR achievedSBPOxygen uptake achieved
-
8/13/2019 CET+and+Interp+ C5 6
11/30
Test Modalities
CycleTM
Arm ergometer
advantages/disadvantages
-
8/13/2019 CET+and+Interp+ C5 6
12/30
Testing Protocols-Fig. 5.3
TMBruce/Modified Bruce
Balke-WareUSAFSAMNaughton/Modified Naughton
CycleYMCAPWC-170
-
8/13/2019 CET+and+Interp+ C5 6
13/30
Treadmill TestingBruce Treadmill Test Stages
Stage 1 = 1.7 mph at 10% GradeStage 2 = 2.5 mph at 12% GradeStage 3 = 3.4 mph at 14% GradeStage 4 = 4.2 mph at 16% GradeStage 5 = 5.0 mph at 18% GradeStage 6 = 5.5 mph at 20% GradeStage 7 = 6.0 mph at 22% GradeStage 8 = 6.5 mph at 24% GradeStage 9 = 7.0 mph at 26% Grade
The Bruce Protocol Formula for Estimating VO2 Max
For Men VO2 max = 14.8 - (1.379 x T) +(0.451 x T) - (0.012 x T)For Women VO2 max = 4.38 x T - 3.9T = Total time on the treadmill measured as a fraction of aminute (i.e.: A test time of 9 minutes 30 seconds would be
written as T=9.5).
-
8/13/2019 CET+and+Interp+ C5 6
14/30
VO2 MaxNorms for
Men -Measured
inml/kg/min
Age Very Poor Poor Fair Good Excellent Superior
13-19 55.9
20-29 52.4
30-39 49.440-49 48.0
50-59 45.3
60+ 44.2
Bruce Norms
-
8/13/2019 CET+and+Interp+ C5 6
15/30
VO2 Maxvalues forWomen asmeasured
in
ml/kg/minAge Very Poor Poor Fair Good Excellent Superior13-19 41.920-29 41.030-39 40.0
40-49 36.950-59 35.760+ 31.4
Bruce Norms
-
8/13/2019 CET+and+Interp+ C5 6
16/30
Functional Aerobic Impairment(FAI)
% FAI = predicted VO2 measured VO2 x 100
predicted VO2
Predicted (male): 57.8 (.445 x age)
Measured: 14.8 - (1.379 x T) + (0.451 x T) -(0.012 x T)
-
8/13/2019 CET+and+Interp+ C5 6
17/30
Example-FAI
50 y/o male
Predicted Vo2 = 57.8 (.445 x 50) = 35.5 ml/kg/min
Measured VO2 = 20.2 ml/kg/min (TM time)
35.5 20.2
FAI = ______________ x 100 = 43%35.5
FAC = 57%
-
8/13/2019 CET+and+Interp+ C5 6
18/30
Protocols cont.
Step wise vs. rampIncrements 8-12 mins
HR, BP & ECG monitored pre-post exercise(6-8 mins or until any changes return to baseline(Table 5.2)RPE, angina scale & claudication scales(Fig.5.4)
-
8/13/2019 CET+and+Interp+ C5 6
19/30
Indications for stopping a test(Box 5.2) Absolute/Relative
Drop in SBP (>10 mmHg) with other signs ifischemia?Mod-severe angina (3 on standard scale)Sustained ventricular tachycardiaST elevation (1.0 mm)Excessive ST depression (>2mm horizontal ordownsloping)arrhythmias
-
8/13/2019 CET+and+Interp+ C5 6
20/30
Gas exchange and ventilatorymeasurements: CP-GXT
Utility:Accuracy of VO2 measurement
Distinguish b/w cardiac and pulmonary limitations(dyspnea)Additional assessments of cardiac function (O2pulse; VTh)Rule out malingering (RER)
-
8/13/2019 CET+and+Interp+ C5 6
21/30
Critical Measurements:
HR, Bp, EKG and signs/symptomsVO2 measured vs. estimated (obesity; lungdisease)
VE airflow limitation? (VE/MVV)RER effortVTh cardiac function
VE/VO2 ; VE/VCO2 ventilating efficiencySaO2 or PaO2 gas exchange limitation?O2 pulse VO2/HR (indirect indicator of SV)
-
8/13/2019 CET+and+Interp+ C5 6
22/30
Thallium 201 Stress Test
(or Technetium99
)
-
8/13/2019 CET+and+Interp+ C5 6
23/30
Thallium Scan
-
8/13/2019 CET+and+Interp+ C5 6
24/30
Echocardiography (Ultrasound)
Transesophageal echocardiogram. Doppler echocardiogram. Stress echocardiogram.
Mitral valveprolapseLVH
-
8/13/2019 CET+and+Interp+ C5 6
25/30
Pharmacological Stress Testing
Dobutamine stress echo detection of wallmotion abnormalities (+ chronotropic agent)
Dipyridamole (persantine) or adenosine vasodilators used to assess coronaryperfusion in conjunction with a nuclearimaging agent (increased blood flow innormal CA; steals blood flow from stenoticvessels)Accuracy = ~86%
-
8/13/2019 CET+and+Interp+ C5 6
26/30
Considerations for PulmonaryPatients-Essential Measurements
Spirometry (FVC, FEV1, MVV, TLC)VE (VE/MVV) -calculation of breathing reserve
airflow limitation SaO2/PaO2 oxygenation gas exchangelimitation; ABG or pulse oximetry
VO2/VCO2 (direct measurements)VT and Fb
-
8/13/2019 CET+and+Interp+ C5 6
27/30
Asthma and Exercise-InducedAsthma (EIA)
Incidence 20 million; by ~5% per year80% of asthmatics have EIA (EIB)
Only 5-15% of non asthmatics have EIAHigh incidence in winter sport athletes (40-50%)
Mechanism : loss of H2O and airway drying histamine from mast cells bronchoconstriction and inflammation
-
8/13/2019 CET+and+Interp+ C5 6
28/30
Asmogenic Agents/Symptoms
Allergensanimal dander, dust mites, pollen
Irritantssmoke, air pollution, cold air, sulfites (wine),chlorine?
Exercise (especially in cold air)
Symptoms
cough, wheeze, dyspnea, chest tightness
-
8/13/2019 CET+and+Interp+ C5 6
29/30
Testing Protocols for EIA(bronchial provocation test)
85% PMHR ( VE)
6-8 mins durationFEV1 measured before and at 5 min intervalsafter exercise
15 % drop in FEV1 = EIA
f
-
8/13/2019 CET+and+Interp+ C5 6
30/30
Testing for PVDAnkle-brachial index (ABI)
Arterial pedal pulses dopplertibialis anteriorposterior pedal
Normal value > .90Example:At rest: ankle = 110 ; brachial = 120 110/120 = .91Moderate-to-Severe Occlusion (post-exercise)ankle = 70; brachial = 140 70/140 = .50